Can Pulmonary Embolism Severity Indices Predict COVID-19-Related Adverse Events?
Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?
Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?
Researchers assessed the safety and efficacy of the QazCovid-in COVID-19 vaccine.
Researchers assessed antibody responses among health care workers 9 months after COVID-19 vaccination.
In this meta-analysis, researchers assessed saliva, gargle, and nasopharyngeal samples for the detection of COVID-19 infection.
Researchers assessed the risk for liver damage among patients with HIV-1 monoinfection receiving antiretroviral therapy.
Researchers conducted a study that compared a multicomponent diagnostic strategy with routine care for the diagnosis and treatment of tuberculosis infection.
Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.
Researchers assessed interest levels and factors associated with interest among first-degree relatives of patients with rheumatoid arthritis.
Researchers conducted a meta-analysis to determine the effectiveness of N95 respirators vs surgical masks in protecting against viral respiratory illness transmission.
Researchers determined the effect of disease-specific distress (DSD) among patients with rheumatoid arthritis (RA) and developed a patient-reported outcome measure to assess DSD in RA.